Randomized Trial of Early Versus Standard Drainage Removal After Pancreatic Resections
Launched by UNIVERSITA DI VERONA · Jul 1, 2009
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergone either pancreaticoduodenectomy (reconstruction by pancreaticojejunostomy) or distal pancreatectomy with an amylase value in drains on postoperative day 1 less than 5000 IU/L
- Exclusion Criteria:
- • Pancreaticoduodenectomy reconstructed with pancreaticogastrostomy
- • Clinical suspect of postoperative haemorrhage within 72hours after the operation
- • Clinical suspect of biliary fistula
- • Fluid collection greater than 3cm at an ultrasound carried out on postoperative day 3
About Universita Di Verona
The Università di Verona is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university collaborates with various healthcare professionals and institutions to explore new therapies and improve patient outcomes. Its research initiatives are driven by a multidisciplinary approach, leveraging cutting-edge technology and methodologies. The Università di Verona aims to contribute significantly to the scientific community and public health by fostering rigorous clinical studies that address pressing medical challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Verona, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials